RT @EBRheum: NEW Draft Guidelines for EGPA presented at #ACR19 @RheumNow 1. TTE and FFS to guide tx 2. GC plus cytoxan or rituxan for acti…
Tweet Content
NEW Draft Guidelines for EGPA presented at #ACR19 @RheumNow
1. TTE and FFS to guide tx
2. GC plus cytoxan or rituxan for active/severe dx
3. Imuran/MMF/MTX for maintenance after severe dx
4. Mepo for non-severe over csDMARDs
Larger role for RTX than expected, overall reasonable https://t.co/MEb10n5Mzd
Show on Archive Page
On
Display in Search Results
On